BRAIN UPTAKE OF CIRCULATING APOLIPOPROTEIN-J AND APOLIPOPROTEIN-E COMPLEXED TO ALZHEIMERS AMYLOID-BETA

被引:130
作者
ZLOKOVIC, BV
MARTEL, CL
MACKIC, JB
MATSUBARA, E
WISNIEWSKI, T
MCCOMB, JG
FRANGIONE, B
GHISO, J
机构
[1] UNIV SO CALIF, CHILDRENS HOSP LOS ANGELES, SCH MED, DIV NEUROSURG, LOS ANGELES, CA 90033 USA
[2] NYU, MED CTR, DEPT PATHOL, NEW YORK, NY 10016 USA
关键词
D O I
10.1006/bbrc.1994.2825
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Amyloid beta (A beta) is a fibrillar component in Alzheimer's disease amyloid deposits and a soluble peptide (sA beta) normally present in body fluids, We have recently reported that the blood-brain barrier (BBB) has a capability to control cerebrovascular sequestration and transport of circulating sA beta. In this study, we examined whether two circulating amyloid-associated proteins shown to bind sA beta, apolipoproteins J (apo J) and E (apo E), can cross the BBB alone and/or complexed to a synthetic peptide homologous to a major form of sA beta, sA beta(1-40). Brain pel fusion experiments in guinea pigs showed significant uptake of both apo J and sA beta(1-40)-apo J complexes. In contrast, blood-brain transport of sA beta(1-40)-apo E was negligible, while apo E had a limited access across the BBB, indicating that the apo E found within the brain is produced locally. It is concluded that sA beta(1-40) binding to apo J and apo E results in significant (> 100-fold) difference in brain uptake of their respective complexes. We hypothesize that in normal brain apo J facilitates sA beta transport. (C) 1994 Academic Press, Inc.
引用
收藏
页码:1431 / 1437
页数:7
相关论文
共 29 条
[1]  
AUDUS KL, 1992, ADV DRUG RES, V23, P1
[2]   DELIVERING PEPTIDES TO THE CENTRAL-NERVOUS-SYSTEM - DILEMMAS AND STRATEGIES [J].
BANKS, WA ;
KASTIN, AJ ;
BARRERA, CM .
PHARMACEUTICAL RESEARCH, 1991, 8 (11) :1345-1350
[3]   GENERATION OF BETA-AMYLOID IN THE SECRETORY PATHWAY IN NEURONAL AND NONNEURONAL CELLS [J].
BUSCIGLIO, J ;
GABUZDA, DH ;
MATSUDAIRA, P ;
YANKNER, BA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (05) :2092-2096
[4]  
GHISO J, 1993, BIOCHEM J, V293, P27, DOI 10.1042/bj2930027
[5]   UNIFYING FEATURES OF SYSTEMIC AND CEREBRAL AMYLOIDOSIS [J].
GHISO, J ;
WISNIEWSKI, T ;
FRANGIONE, B .
MOLECULAR NEUROBIOLOGY, 1994, 8 (01) :49-64
[6]   ALZHEIMERS-DISEASE - INITIAL REPORT OF THE PURIFICATION AND CHARACTERIZATION OF A NOVEL CEREBROVASCULAR AMYLOID PROTEIN [J].
GLENNER, GG ;
WONG, CW .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1984, 120 (03) :885-890
[7]   AMYLOID BETA-PEPTIDE IS PRODUCED BY CULTURED-CELLS DURING NORMAL METABOLISM [J].
HAASS, C ;
SCHLOSSMACHER, MG ;
HUNG, AY ;
VIGOPELFREY, C ;
MELLON, A ;
OSTASZEWSKI, BL ;
LIEBERBURG, I ;
KOO, EH ;
SCHENK, D ;
TEPLOW, DB ;
SELKOE, DJ .
NATURE, 1992, 359 (6393) :322-325
[8]  
JOHANNSON BG, 1972, SCAND J CLIN LA S124, V29, P136
[9]   CONSERVATION OF THE SEQUENCE OF THE ALZHEIMERS-DISEASE AMYLOID PEPTIDE IN DOG, POLAR BEAR AND 5 OTHER MAMMALS BY CROSS-SPECIES POLYMERASE CHAIN-REACTION ANALYSIS [J].
JOHNSTONE, EM ;
CHANEY, MO ;
NORRIS, FH ;
PASCUAL, R ;
LITTLE, SP .
MOLECULAR BRAIN RESEARCH, 1991, 10 (04) :299-305
[10]  
KOUDINOV A, 1994, UNPUB